Upon completion of this virtual course, learners should be able to: 

• Discuss state-of-the-art research in endocrinology.
• Practice updated clinical skills for more effective diagnosis, management, and treatment of endocrine disorders and related sequelae.
• Apply updated knowledge and clinical skills in improving patient care.
• Construct new research questions based on updated scientific and clinical advances in endocrinology related disciplines

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

For questions about content or obtaining CME credit, please contact the Endocrine Society at eventeducation@endocrine.org

STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.

DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The following Annual Meeting Steering Committee members reported relevant financial relationships:

Irina Bancos, MD, Elsevier, writer, Dynamed, reviewer, Endocrine Society Educational initiatives

Stephanie Anne Fish, PhD, American Board of Internal Medicine, write questions for endocrine maintenance of certification

Lauren Michelle Fishbein, MD, PhD, Lantheus/Azedra, Consultant, Endocrine Society, Associate Editor Endocrine Review

Christa E. Flueck, MD, Novo Nordisk, advisor, grantee, Merck, grantee, Pfizer, advisor, grantee, Sandoz, grantee, speaker, EffRx, advisor, Swiss National Science Foundation, grantee, European Society Paediatric Endocrinology, grantee, committee member

Daniel E. Frigo, PhD, -GTx, Inc, paid consultant and laboratory funding, Hummingbird Bioscience, Maia Biotechnology,-Alms Therapeutics,-Barricade Therapeutic, -Hinova Pharmaceuticals, Inc.

Ole-Petter Hamnvik, MBBChBAO, MMSc, MRCPI, Education Editor: New England Journal of Medicine

Edward Chiaming Hsiao, MD, PhD, Clementia Pharmaceuticals/Ipsen Pharmaceuticals: Clinical trials site investigator at UCSF, Ultragenyx: Clinical trials site investigator at UCSF

Shingo Kajimura, PhD, Seminar Speaker, Novo Nordisk, Eli Lilly Amgen

Niki Karavataki, MSc, PhD, FRCP, Recordati Rare Diseases, Speaker, HRA Pharma, Speaker, Editorial Board, Pfizer, Speaker, Ipsen, Speaker, Conselient Health, Speaker

Katja Kiseljak-Vassiliades, DO, HRA Pharma, Adrenocortical carcinoma Advisory Board

Ellis R. Levin, MD, Stock Owner: Gilead Inc., Amgen

Raghavendra Mirmira, PhD, MD, Editor: Journal of Clinical Endocrinology and Metabolism, Advisory Board: Veralox Therapeutics

Gabrielle Page-Wilson, MD, Advisory Board: Strongbridge Biopharma, Recordati Rare Diseases, Inc., Xeris BioPharma; Consultant: Xeris BioPharma

Matti Poutanen, PhD, Aboendo, Founder & CEO, Forendo Pharma, Advisor, Organon Co., Advisor

Yumie Rhee, MD, PhD, Associate Editor, JCEM Case Reports

W. Edward Visser, MD, PhD, Royalties (Institution): Egetis Therapeutics

Selma Witchel, MD, Journal of the Endocrine Society, Editorial Board, Steroids, Associate Editor

Bu Beng Yeap, MBBS, FRACP, PhD, Advisory Board: NovoNordisk, Bayer, Advisor: Lawley Pharmaceuticals, Speaker: AstraZeneca, Besins, Philippine Society for Endocrinology, Diabetes and Metabolism, View Street Medical, President: Endocrine Society of Australia, Associate Editor: Asian Journal of Andrology, Journal of Gerontology Medical Sciences, Editorial Board: Journal of Gerontology Medical Sciences, Journal of Clinical Endocrinology and Metabolism, Maturitas

Elaine Wei-Yin Yu, MD, Grant Recipient: Amgen, Stock Owner: Opko

The following AMSC members reported no relevant financial relationships:

Ana Paula Abreu, MD, PhD; Benson Akingbemi, PhD, DVM; Olga Astapova, MD, PhD; Denise Belsham, PhD; Ernesto Bernal-Mizrachi, MD; Daniel Bernard, PhD; Laura Boucai, MD; Davide Calebiro, MD, Barbara Gisella Carranza Leon, MD; Aime Franco, PhD; Hebatullah Ismail, MD; Carolin Hurtado, MD; Srividya Kidambi, MD; T. Raj Kumar, PhD, MPHIL, MSC; Erik Nelson, BSc, PhD; Claire Newton, BSc, PhD; Bernice Omotosho, MD; Ines Pineda Torra PhD; Claudia Ramirez, MD; Kanakadurga Singer, MD; Dominique Stephens, PhD; Marc J. Tetel, PhD; and Jun Yang, MBBS, PhD, FRACP.

Disclosure information for presenters is included in their individual recorded presentations.

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.